NCT02176018View on ClinicalTrials.gov

Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
Episodic Migraine
Interventions
DRUG

Dextromethorphan and quinidine

DRUG

Placebo

Trial Locations (5)

11803

Island Neurological Associates, PC, Plainview

39157

The Headache Center, Ridgeland

61104

Swedish American Neuro and Headache Center, Rockford

63303

StudyMetrix Research, LLC, City of Saint Peters

65807

Clinvest, Springfield

Sponsors

Collaborators (1)

Avanir Pharmaceuticals
All Listed Sponsors
collaborator

Avanir Pharmaceuticals

INDUSTRY

lead

Cady, Roger, M.D.

INDIV